Reaching the hard to reach: Characteristics of patients who received a COVID‐19 vaccine in the emergency department
| Autor: | Jonathan V. McCoy, Jessica Rowley, Robert Eisenstein, Sara W Heinert |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Emergency Use Authorization
2019-20 coronavirus outbreak COVID-19 Vaccines Coronavirus disease 2019 (COVID-19) SARS-CoV-2 business.industry Safety net MEDLINE COVID-19 General Medicine Emergency department medicine.disease Food and drug administration Regimen Research Letter Emergency Medicine Humans Medicine Medical emergency Emergency Service Hospital business |
| Zdroj: | Academic Emergency Medicine |
| ISSN: | 1553-2712 1069-6563 |
| Popis: | In February 2021, the U.S. Food and Drug Administration (FDA) provided Emergency Use Authorization for the Janssen vaccine- the first one-dose COVID-19 vaccine to become available in the U.S. The one-dose regimen expanded opportunity to vaccinate in settings that can reach vulnerable communities for which returning to a site for a second vaccine dose may prove difficult. With 139 million visits annually in the U.S.1 and a tendency to serve in a safety net capacity for underserved patients2 , the emergency department (ED) is one such setting. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text